Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF-001 cream in adult psoriasis vulgaris (Phase 2)
ChiCTR2600120703Phase 2Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of TAF-001 in plaque psoriasis (4 arms), sponsored by Peking University People's Hospital. Primary endpoint: mPASI 75 response rate. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
TAF-001
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ChiCTR2600120703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120703.